Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (931)
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Oei Khing Djien — Director
Shares
168,750
Price
$3.92
Total Value
$661.50K
Shares Held After
0
% of Holdings
100.0%
Kura Oncology, Inc. (KURA)
Burrows Francis — Chief Scientific Officer
Shares
20,726
Price
$10.83
Total Value
$224.51K
Shares Held After
42,327
% of Holdings
32.9%
Oric Pharmaceuticals, Inc. (ORIC)
Piscitelli Dominic — Chief Financial Officer
Shares
500
Price
$13.51
Total Value
$6.75K
Shares Held After
69,828
% of Holdings
0.7%
Oric Pharmaceuticals, Inc. (ORIC)
Piscitelli Dominic — Chief Financial Officer
Shares
100
Price
$13.50
Total Value
$1.35K
Shares Held After
70,328
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$480.33
Total Value
$19.21K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$479.52
Total Value
$287.71K
Shares Held After
324,483
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,480
Price
$478.61
Total Value
$708.34K
Shares Held After
325,083
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$477.58
Total Value
$171.93K
Shares Held After
326,563
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$476.51
Total Value
$133.42K
Shares Held After
326,923
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$475.35
Total Value
$152.11K
Shares Held After
327,203
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
437
Price
$474.01
Total Value
$207.14K
Shares Held After
327,523
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
580
Price
$472.73
Total Value
$274.18K
Shares Held After
327,960
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,160
Price
$471.77
Total Value
$1.02M
Shares Held After
328,540
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,603
Price
$470.63
Total Value
$1.23M
Shares Held After
330,700
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$469.74
Total Value
$300.63K
Shares Held After
333,303
% of Holdings
0.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
39,000
Price
$98.99
Total Value
$3.86M
Shares Held After
341,209
% of Holdings
10.3%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,846
Price
$36.36
Total Value
$103.48K
Shares Held After
176,545
% of Holdings
1.6%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Martin Patricia A. — Director
Shares
50,000
Price
$3.86
Total Value
$193.00K
Shares Held After
118,750
% of Holdings
29.6%
Pharvaris N.V. (PHVS)
Monges Viviane — Director
Shares
11,969
Price
$33.05
Total Value
$395.52K
Shares Held After
5,500
% of Holdings
68.5%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
7,401
Price
$21.03
Total Value
$155.65K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
5,099
Price
$20.19
Total Value
$102.97K
Shares Held After
7,401
% of Holdings
40.8%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$500.05
Total Value
$120.01K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
90
Price
$498.90
Total Value
$44.90K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
270
Price
$498.38
Total Value
$134.56K
Shares Held After
324,773
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
766
Price
$497.27
Total Value
$380.91K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
525
Price
$496.38
Total Value
$260.60K
Shares Held After
325,809
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
155
Price
$495.17
Total Value
$76.75K
Shares Held After
326,334
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$493.72
Total Value
$79.00K
Shares Held After
326,489
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$492.54
Total Value
$236.42K
Shares Held After
326,649
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$491.65
Total Value
$405.12K
Shares Held After
327,129
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,440
Price
$490.48
Total Value
$706.29K
Shares Held After
327,953
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,162
Price
$489.52
Total Value
$1.06M
Shares Held After
329,393
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,388
Price
$488.70
Total Value
$1.17M
Shares Held After
331,555
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
43
Price
$41.05
Total Value
$1.77K
Shares Held After
456,767
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
215
Price
$39.86
Total Value
$8.57K
Shares Held After
456,810
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,952
Price
$39.05
Total Value
$76.23K
Shares Held After
457,025
% of Holdings
0.4%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
30,000
Price
$99.40
Total Value
$2.98M
Shares Held After
380,209
% of Holdings
7.3%
Mineralys Therapeutics, Inc. (MLYS)
Slingsby Brian Taylor — Director
Shares
104,320
Price
$28.81
Total Value
$3.01M
Shares Held After
7,805,718
% of Holdings
1.3%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
IMPACT BIOMEDICAL INC. (IBO)
DSS, INC. — 10% Owner
Shares
723
Price
$0.55
Total Value
$397.65
Shares Held After
589,701
% of Holdings
0.1%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
10,400
Price
$60.24
Total Value
$626.46K
Shares Held After
94,784
% of Holdings
9.9%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,088
Price
$1.65
Total Value
$1.80K
Shares Held After
4,528
% of Holdings
19.4%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
27,612
Price
$1.65
Total Value
$45.56K
Shares Held After
114,851
% of Holdings
19.4%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
100
Price
$195.15
Total Value
$19.52K
Shares Held After
4,333
% of Holdings
2.3%
Revolution Medicines, Inc. (RVMD)
ANDERSON ELIZABETH M — Director
Shares
1,500
Price
$194.59
Total Value
$291.88K
Shares Held After
4,433
% of Holdings
25.3%
Showing 1–50 of 931 transactions (page 1 of 19)